Institute of Child Health
57
1
2
36
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
3.5%
2 terminated/withdrawn out of 57 trials
94.7%
+8.2% vs industry average
25%
14 trials in Phase 3/4
3%
1 of 36 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (57)
UNICORNS: Uveitis in Childhood Prospective National Cohort Study
Role: lead
The Mosaic Brain: a New Diagnostic Approach in Focal Epilepsies
Role: lead
Exploring Bulbar Function, Speech And Communication Development in SMA Type 1
Role: lead
The Great Ormond Street Hospital Top Child and Adolescent Health Study
Role: lead
Tube Feeding in Children Having a Bone Marrow Transplant
Role: lead
Imaging Based Uveitis Screening for Children With Juvenile Idiopathic Arthritis
Role: lead
Homonymous Hemianopia in Childhood
Role: lead
Alternative Substrates in the Critically Ill Subject
Role: collaborator
Natural History Study of ATP1A3-related Disease
Role: lead
Strengthening Bangladeshi Babies Brains (SBBB)
Role: collaborator
CATCH - Catheter Infections in Children
Role: lead
Open vs Laparoscopic Pyloromyotomy for Pyloric Stenosis
Role: lead
Minimal Access Repair of Contralateral Hernias (MARCH Trial)
Role: lead
Neuropathic Pain in Children: Multimodal Assessment and Diagnosis
Role: lead
Microbial Invasion During Parenteral Nutrition in Surgical Infants Receiving Glutamine
Role: lead
Gene Therapy for Wiskott-Aldrich Syndrome (WAS)
Role: collaborator
A Trial Comparing Two Pertussis-containing Vaccines in Pregnancy and Vaccine Responses in UK Mothers and Their Infants
Role: collaborator
Assessment of Novel Pneumococcal Conjugate Vaccination Scheduled in UK Infants
Role: collaborator
Macrolide in Pregnancy and Adverse Child Outcomes
Role: lead
Study to Evaluate the Immune Response of United Kingdom (UK) Infants Receiving DTaP/Hib/IPV, Meningococcal C Conjugate and Pneumococcal Conjugate Vaccines, Antibody Persistence and Responses to Booster Doses in the Second Year of Life
Role: collaborator